Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving Hepatocellular Carcinoma Surveillance in Ambulatory Hepatology: A PDSA Quality Improvement Initiative.

Nursing reports (Pavia, Italy)·2026
Same author

Multi-modal machine learning highlights recipient genetic and clinical factors as primary drivers of post-transplant MASLD: A two-center study.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same author

Social determinants of health: a priority for internal medicine. Position statement of the Spanish Society of Internal Medicine (SEMI) and the Portuguese Society of Internal Medicine (SPMI).

Revista clinica espanola·2026
Same author

Contaminating plasmid sequences and disrupted vector genomes in the liver following adeno-associated virus gene therapy.

Nature medicine·2026
Same author

Typhi Mykrobe: fast and accurate lineage identification and antimicrobial resistance genotyping directly from sequence reads for the typhoid fever agent Salmonella Typhi.

Genome medicine·2025
Same author

Microbiology and epidemiology of enteroaggregative <i>Escherichia coli</i> isolated from UK residents in England, 2016-2023: what are the risks to public health?

Journal of medical microbiology·2025
Same journal

Filtered or Fried? Rethinking Intraoperative Cell Salvage in Liver Transplantation.

Transplantation·2026
Same journal

Simultaneous Liver-kidney Versus Liver Transplantation Categorized by Pretransplant eGFR: Impact of the 2017 OPTN Policy.

Transplantation·2026
Same journal

Preformed Anti-DQ Alpha Donor-specific Antibodies and the Risk of Antibody-mediated Rejection After Kidney Transplantation.

Transplantation·2026
Same journal

People in Transplantation: Professor Nadey Hakim, MD, PhD, FRCS, FRCSGlas (Hon), FACS, President-Elect of The Transplantation Society.

Transplantation·2026
Same journal

IL-1 Receptor Blockade Modulates Inflammation During Sequential Perfusion in Ex Vivo Porcine Kidneys.

Transplantation·2026
Same journal

Regulatory T Cells Allosensitized Under the Blockade of CD80/CD86-CD28 Costimulation Prolonged Islet Allograft Survival.

Transplantation·2026
See all related articles

Related Experiment Video

Updated: Apr 19, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

15.0K

Steroid-free Liver Transplantation Using Rabbit Antithymocyte Globulin Induction in 500 Consecutive Patients.

Min C Yoo1, Jason M Vanatta, Kian A Modanlou

  • 11 Transplantation, University of Tennessee/Methodist University Hospital Transplant Institute, Memphis, TN.

Transplantation
|December 25, 2014
PubMed
Summary
This summary is machine-generated.

This study shows a steroid-free immunosuppression protocol using rabbit antithymocyte globulin (RATG) induction in liver transplantation offers excellent patient survival and preserves kidney function in a large patient cohort.

More Related Videos

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
11:25

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

1.0K
Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

8.6K

Related Experiment Videos

Last Updated: Apr 19, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

15.0K
Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
11:25

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

1.0K
Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

8.6K

Area of Science:

  • Nephrology
  • Immunology
  • Transplantation

Background:

  • Steroid-free immunosuppression protocols are increasingly explored in organ transplantation.
  • Rabbit antithymocyte globulin (RATG) induction has demonstrated efficacy in liver transplantation.
  • Tacrolimus minimization strategies aim to reduce drug-related toxicities.

Purpose of the Study:

  • To evaluate the benefits of a steroid-free immunosuppression protocol with RATG induction.
  • To assess outcomes in a large cohort of orthotopic liver transplantation (OLT) recipients.
  • To demonstrate the long-term efficacy and safety of this immunosuppressive regimen.

Main Methods:

  • A cohort of 500 OLT recipients received RATG induction and a single dose of solumedrol.
  • Mycophenolate mofetil was initiated postoperatively, with delayed tacrolimus initiation.
  • Sirolimus replaced tacrolimus if serum creatinine exceeded 2.0 mg/dL; patients were weaned to monotherapy at 3 months.

Main Results:

  • One-year patient and graft survival rates were 92.8% and 89.6%, respectively.
  • Renal function improved post-transplant, with glomerular filtration rate increasing by 1 year.
  • Pretransplant creatinine was a significant predictor of patient and graft survival.

Conclusions:

  • This large series confirms excellent outcomes for steroid-free RATG induction in OLT.
  • The protocol demonstrates low complication rates and preservation of renal function.
  • Steroid-free immunosuppression with RATG is a viable option for OLT.